Clinical Trial Update: Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial is investigating hypofractionated radiotherapy followed by chemo-immunotherapy induction in limited-stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Lung Cancer, Small Cell, Limited-stage Small Cell Lung Cancer (LS-SCLC) | Phase 2 | Status: NOT_YET_RECRUITING